S

Seattle Allergy and Asthma Research Institute | Seattle, WA

Research site
(Unclaimed)
Location
9725 Third Avenue NE, Suite 500, Seattle, Washington, United States of America

Site insights

Top conditions

Top treatments

Dupilumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis (ENGAGE)

The study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or...

Enrolling
Eosinophilic Gastrointestinal Disease
Eosinophilic Gastritis
Drug: Matching Placebo
Drug: Dupilumab Dose 2

This is a Phase 1b/2, randomized, double-blind, multi-center study to evaluate the safety, tolerability, and preliminary clinical efficacy of STMC-10...

Active, not recruiting
Atopic Dermatitis
Type 1 Hypersensitivity
Biological: Placebo
Biological: STMC-103H

Trial sponsors

Regeneron Pharmaceuticals logo
Siolta Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems